Pathology Lectures

Atherosclerotic Ischemic Renal Disease

64 slides · PPTX & PDF available

Download PDF
Request PowerPoint

PowerPoint animations are preserved in the original file.

Marks are temporary. Tap a drawing tool again to stop.
Slide index (64)
  1. Loading slide titles…

Loading presentation…

Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.

Lecture topics

Slide index & full transcript (64 slides)

Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.

Slide 1 · Atherosclerotic

Ischemic Renal Disease

Renal vascular pathology • Mechanisms, morphology, clinical correlation

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Differentiate renovascular hypertension from ischemic renal insufficiency.

Explain how atherosclerotic renal artery stenosis affects renal blood flow.

Identify gross and microscopic consequences of chronic hypoperfusion.

Distinguish large-artery stenosis from other renal vascular lesions.

Interpret two-kidney physiology and relevant diagnostic principles.

Slide 3 · Renal perfusion depends on large-artery inflow

AORTA

Renal artery

Renal artery

Narrowing at the renal artery origin can limit downstream perfusion.

Slide 4 · Definition and scope

Chronic renal hypoperfusion caused by atherosclerotic narrowing of the renal arteries

The clinical expression depends on lesion distribution, severity, duration, and preexisting parenchymal injury.

Slide 5 · The central disease pathway

Atherosclerotic plaque

Typically near the renal artery origin

Narrowed lumen

Less pressure and flow distal to the lesion

Chronic renal ischemia

Sustained reduced perfusion

Renal insufficiency

Progressive loss of functional renal tissue

The same lesion can also initiate renovascular hypertension.

Slide 6 · Two overlapping presentations

Pattern

Dominant physiologic effect

Teaching consequence

Unilateral stenosis

Renin release from an ischemic kidney

Secondary renovascular hypertension

Bilateral disease

Perfusion compromise in both kidneys

Renal insufficiency; Hypertension may be absent

Coexisting lesions

Vascular and parenchymal processes overlap

Mixed clinical and morphologic phenotype

Slide 7 · An important diagnostic paradox

Ischemic renal insufficiency may occur without hypertension

Bilateral atherosclerotic renal artery disease can be associated with renal dysfunction even when hypertension is absent.

Slide 8 · The characteristic clinical setting

Atherosclerotic narrowing is especially relevant in older individuals.

The parent renal artery stenosis section describes increasing frequency with age and diabetes.

Renal function may deteriorate gradually when both kidneys have impaired inflow.

Hypertension is neither required nor sufficient to establish ischemic renal disease.

Slide 9 · Atherosclerosis is the principal cause of renal artery stenosis

The typical plaque is located near the arterial origin

The Robbins source reports atherosclerotic narrowing at the renal artery origin as the most common cause of renal artery stenosis (approximately 70%).

Slide 10 · Atherosclerotic lesions often occupy the renal artery origin

Schematic arterial cross-section

Plaque site

Near the aortic origin of the renal artery

Lumen

Narrowing reduces the perfusion pathway

Superimposed change

Thrombosis may complicate the plaque

Slide 11 · Ostial plaques: Important morphologic details

The lesion often narrows the proximal artery at its origin from the aorta.

The plaque as usually concentric.

Thrombosis may be superimposed on the atheroma.

Proximal inflow obstruction can affect the entire downstream kidney.

Slide 12 · Atheroma plus thrombosis can intensify obstruction

Proximal plaque

Fixed atheromatous narrowing

Superimposed thrombus

Additional reduction in luminal area

Lower distal perfusion

Greater ischemic burden

Parenchymal injury

Functional or structural consequences

Thrombosis is described as a possible superimposed change, not a universal event.

Slide 13 · Atherosclerosis versus fibromuscular dysplasia

Feature

Atherosclerosis

Fibromuscular dysplasia

Age setting

Typically older patients

Typically younger adults

Sex association

More frequent in males

More frequent in females

Lesion

Atheromatous plaque near origin

Fibrous/fibromuscular arterial thickening

Distribution

Often proximal ostial lesion

Can involve intima, media or adventitia

Slide 14 · Stenosis creates a perfusion-pressure problem

Anatomic narrowing

Higher resistance to flow

Reduced downstream pressure

Signals to ischemic kidney

Functional response

Renin–angiotensin system activation

Systemic effect

Increased blood pressure

Slide 15 · Systemic blood pressure does not equal intrarenal perfusion

An elevated systemic pressure can coexist with a poorly perfused kidney

A proximal arterial lesion can separate pressure in the aorta from pressure experienced by the downstream renal circulation.

Slide 16 · Unilateral stenosis: Asymmetrical perfusion and pressure effects

AORTA

Reduced arterial inflow

Relatively preserved inflow

Renin from the ischemic kidney can drive systemic hypertension.

Slide 17 · The ischemic kidney activates renin secretion

Reduced renal perfusion

Signal at juxtaglomerular apparatus

Renin release

Endocrine response to ischemia

Angiotensin II generation

Vasoconstrictor pathway

Systemic hypertension

Raised vascular resistance

Slide 18 · Why renin matters in renovascular hypertension

Increased renin production by the ischemic kidney as the principal initiating mechanism.

Renin secretion activates the angiotensin pathway.

Angiotensin II is a potent vasoconstrictor.

The pressure response depends on the extent of arterial narrowing.

Slide 19 · Renin–angiotensin sequence

Renal ischemia

Juxtaglomerular renin secretion

RAAS activation

Downstream hormonal cascade

Angiotensin II

Systemic arteriolar constriction

Hypertension

Rise in arterial pressure

Slide 20 · Angiotensin II is the early vasoconstrictor effector

Arterial constriction raises systemic vascular resistance

Angiotensin II in the initial elevation of blood pressure following renal artery constriction.

Slide 21 · Sodium retention contributes to sustained hypertension

Renin–angiotensin activation initiates the pressure rise.

Sodium retention as a contributor to the maintenance of hypertension.

Long-standing hypertension need not remain dependent on one isolated signal.

Mechanisms of pressure maintenance should be distinguished from the stenotic lesion itself.

Slide 22 · Goldblatt physiology links stenosis to blood pressure

Renal artery constriction

Experimental change in inflow

Ischemic kidney

Release of renin

Angiotensin II

Hormone-mediated vasoconstriction

Blood pressure rise

Effect scales with narrowing

Slide 23 · The stenosis–hypertension relationship is not purely structural

A vascular lesion initiates endocrine and hemodynamic adaptation

Renin–angiotensin activation as an initiating mechanism, with other factors potentially maintaining hypertension.

Slide 24 · Bilateral stenosis: Diminished inflow to both kidneys

AORTA

Reduced arterial inflow

Reduced arterial inflow

Chronic ischemia can impair total renal function.

Slide 25 · Bilateral stenosis threatens total functional renal mass

Both renal arteries affected

Inflow to both kidneys impaired

Sustained hypoperfusion

Chronic parenchymal ischemia

Atrophy and scarring

Reduced functional nephron mass

Renal insufficiency

Declining aggregate function

Slide 26 · Why hypertension can be absent in bilateral disease

Renal insufficiency is a perfusion-related outcome, not a diagnostic synonym for hypertension

Robbins explicitly separates chronic ischemic renal insufficiency from the obligatory presence of hypertension.

Slide 27 · Persistent ischemia produces chronic renal injury

Impaired arterial inflow

Reduced perfusion reserve

Ongoing parenchymal stress

Tubular and glomerular damage

Atrophy and fibrosis

Loss and replacement of renal tissue

Smaller kidney

Reduced mass and function

Slide 28 · The ischemic kidney becomes smaller

The ischemic kidney as reduced in size.

Diffuse atrophy reflects loss of viable renal parenchyma.

Tubular atrophy and interstitial fibrosis are central correlates.

Kidney size alone cannot identify the precise cause of chronic injury.

Slide 29 · Renal atrophy is a tissue consequence, not a plaque image

A small kidney demonstrates chronic loss of parenchyma

Direct demonstration of the arterial narrowing and evaluation of competing causes are distinct diagnostic tasks.

Slide 30 · Glomerular crowding reflects loss of surrounding parenchyma

Illustration only — not tissue microscopy

Atrophic ischemic kidney

Reduced tubular volume

Glomeruli appear closer together

Slide 31 · Tubular atrophy is a major component of chronic ischemia

Illustration only — not tissue microscopy

Sustained reduced flow

Tubular epithelial loss and shrinkage

Reduced tubular profiles and function

Slide 32 · Interstitial fibrosis records chronic parenchymal damage

Illustration only — not tissue microscopy

Prolonged vascular insufficiency

Tubulointerstitial injury

Fibrous replacement of lost tissue

Slide 33 · Focal inflammatory infiltrates may accompany chronic injury

Illustration only — not tissue microscopy

Chronic ischemic injury

Interstitial response

Focal inflammatory infiltrates

Slide 34 · Arterioles downstream may be relatively protected

The stenotic kidney receives less of the systemic pressure load.

Its arterioles commonly show only mild arteriolosclerosis.

This can coexist with pronounced parenchymal atrophy.

Severity of pressure-related arteriolar change need not parallel ischemic tissue loss.

Slide 35 · The contralateral kidney experiences a different hemodynamic environment

The well-perfused kidney may show more severe arteriolosclerosis

The severity depends on the hypertension experienced by the contralateral kidney.

Slide 36 · Two kidneys in unilateral renovascular hypertension

Tissue feature

Stenotic kidney

Contralateral kidney

Pressure exposure

Reduced by upstream stenosis

Exposed to systemic hypertension

Size and atrophy

Often small and diffusely atrophic

Not necessarily ischemic from this lesion

Arteriolosclerosis

May be comparatively mild

May be more severe

Dominant driver

Hypoperfusion

Pressure-related vascular injury

Slide 37 · The morphologic triad is not etiologically specific

Glomerular changes + tubular atrophy + interstitial fibrosis

Atherosclerotic ischemic disease must be interpreted together with arterial disease and the distribution of renal injury.

Slide 38 · Nephrosclerosis overlaps with chronic ischemic renal injury

Nephrosclerosis includes glomerulosclerosis, tubulointerstitial scarring, arteriosclerosis and arteriolosclerosis.

Hypertension and age are important associations, but not exclusive explanations.

Small-vessel narrowing produces focal renal ischemia.

Large-artery atherosclerotic stenosis represents a different anatomic level of perfusion limitation.

Slide 39 · Nephrosclerosis can amplify parenchymal ischemia

Intimal and medial thickening

Narrowing of small arteries

Arteriolar hyalinization

Further luminal reduction

Focal hypoperfusion

Ischemic nephron injury

Scarring

Glomerulosclerosis and tubular loss

Slide 40 · Hyaline arteriolosclerosis acts within the microcirculation

Protein-rich hyaline material thickens arteriolar walls

The narrowed lumens contribute to focal parenchymal ischemia. This is distinct from an ostial renal artery plaque.

Slide 41 · Fibroelastic hyperplasia affects intrarenal arteries

Interlobular and arcuate arteries can show medial hypertrophy.

Replication of the internal elastic lamina and intimal tissue accumulation narrow lumens.

These changes increase with age and hypertension.

Unlike renal artery ostial atheroma, this is an intrarenal vessel-wall process.

Slide 42 · From microvascular hypoperfusion to glomerular loss

Small-vessel narrowing

Focal reduction in perfusion

Glomerular ischemia

Capillary tuft and GBM changes

Sclerosis

Collagen and nephron loss

Tubular dropout

Regional interstitial scar

Slide 43 · Chronic atrophy versus renal infarction

Feature

Chronic ischemic atrophy

Renal infarction

Time course

Persistent or progressive hypoperfusion

Abrupt vascular occlusion

Morphology

Diffuse or patchy atrophy and fibrosis

Coagulative necrosis and later scar

Gross pattern

Renal shrinkage

Classically wedge-shaped pale lesion

Clinical link

Progressive renal insufficiency

May be painful or clinically silent

Slide 44 · Large-vessel stenosis and microvascular narrowing act at different levels

Renal artery

Ostial atheromatous plaque

Small artery

Fibroelastic intimal changes

Arteriole

Wall hyalinization

Slide 45 · Clinical expression is often nonspecific

Older patients with renal artery stenosis may resemble those with essential hypertension.

Atherosclerotic bilateral disease may present primarily as renal insufficiency.

Symptoms and examination alone do not define arterial anatomy.

Diagnostic interpretation must connect vascular findings with renal functional impairment.

Slide 46 · No classic symptom reliably establishes renal artery stenosis

Clinical suspicion and anatomic localization are separate steps

That distinctive clinical features are few, even in renovascular hypertension.

Slide 47 · A renal bruit is a possible clue, not proof

A bruit may occasionally be heard over an affected kidney.

Auscultation does not locate or grade an arterial lesion.

Absence of a bruit is not an exclusion criterion.

A bruit belongs in a broader evaluation rather than functioning as a stand-alone diagnosis.

Slide 48 · Renin testing reflects physiology, not arterial anatomy

Renovascular hypertension is initiated by renin from the ischemic kidney.

Elevated plasma or renal-vein renin as potentially helpful.

Renin values do not, by themselves, demonstrate the location of stenosis.

Endocrine and structural assessments address different questions.

Slide 49 · Response to angiotensin blockade supports pathway involvement

Functional response is not equivalent to lesion localization

Blood pressure reduction with medications that block angiotensin II activity in renovascular hypertension; This slide is mechanistic, not prescribing advice.

Slide 50 · Anatomic and functional evaluation answer different questions

Morphology suggests the effect of chronic vascular insufficiency on parenchyma.

Renal scans and intravenous pyelography are mentioned clinical discussion.

These tests are described as diagnostic aids, not as histologic evidence.

The cited source uses arteriography for definitive anatomic localization.

Slide 51 · Arteriography localizes a stenotic arterial lesion

A demonstrable narrowing establishes anatomy; Attribution of renal dysfunction requires interpretation

Arteriography as necessary to localize stenosis in its renal artery stenosis discussion and commonly used for bilateral disease.

Slide 52 · Clinicopathologic diagnostic synthesis

Identify phenotype

Hypertension, renal insufficiency or both

Assess parenchyma

Atrophy and chronic scarring

Evaluate vessels

Atherosclerotic renal artery narrowing

Integrate causality

Does vascular lesion explain the renal findings?

Do not assume every detected stenosis is causative.

Slide 53 · Recognizing revascularizable disease matters

Surgical revascularization can prevent further loss of renal function in selected ischemic disease.

This is a conditional statement of potential benefit, not a universal indication.

Established parenchymal scarring and competing injury may limit functional recovery.

Contemporary procedural decisions require evidence and guidelines beyond this textbook excerpt.

Slide 54 · Vascular correction and parenchymal recovery are not synonymous

Restoring arterial inflow does not automatically reverse established renal scarring

This is a pathophysiologic inference from the parent morphology section; Robbins gives no universal recovery guarantee for ischemic renal disease.

Slide 55 · Differential: Atherosclerotic stenosis and fibromuscular dysplasia

Axis

Atherosclerotic disease

Fibromuscular dysplasia

Typical context

Older; Age and diabetes association

Younger; Female predominance

Wall pathology

Atheromatous plaque

Fibrous/fibromuscular thickening

Usual mechanism

Large-artery inflow limitation

Large-artery inflow limitation

Interpretation

Can impair bilateral renal function

More often taught as a cause of renovascular HTN

Slide 56 · Differential: Fixed stenosis and atheroembolic disease

Axis

Atherosclerotic ischemic disease

Atheroembolic renal disease

Vascular process

Fixed renal artery narrowing

Plaque material embolizes distally

Anatomic site

Proximal renal artery

Intrarenal arterial branches

Histologic clue

Chronic parenchymal atrophy

Cholesterol-cleft emboli

Clinical setting

Chronic ischemic insufficiency

Often after arterial instrumentation

Slide 57 · Differential: Large-artery disease and thrombotic microangiopathy

Axis

Atherosclerotic ischemia

TMA

Principal level

Renal artery inflow lesion

Capillaries and arterioles

Characteristic injury

Chronic hypoperfusion and atrophy

Microthrombi and endothelial injury

Associated pattern

Renovascular HTN or renal insufficiency

Hemolysis, thrombocytopenia, ischemia

Specific mechanism

Atheromatous narrowing

Diverse toxin/complement/platelet pathways

Slide 58 · Differential: Chronic ischemia and acute infarction

Axis

Chronic atherosclerotic hypoperfusion

Renal infarct

Vascular event

Sustained stenosis

Usually embolic occlusion

Parenchymal lesion

Atrophy, fibrosis and renal shrinkage

Wedge-shaped ischemic coagulative necrosis

Clinical course

Can be insidious

May cause costovertebral pain and hematuria

Pathologic point

Viable but chronically injured nephrons

Established necrosis and subsequent scarring

Slide 59 · Case 1: Asymmetric renovascular hypertension

Clinical vignette

An older patient with hypertension has severe proximal narrowing of one renal artery. The affected kidney is smaller; Its intrarenal arteriolar disease is comparatively mild.

Interpret

How can severe hypertension coexist with relatively little arteriolosclerosis in the affected kidney?

Explanation

Upstream stenosis reduces pressure exposure in that kidney; Renin release raises systemic blood pressure, affecting the contralateral kidney.

Slide 60 · Case 2: Renal insufficiency without hypertension

Clinical vignette

An older individual has slowly declining renal function and bilateral atherosclerotic renal artery disease, but does not have sustained hypertension.

Interpret

Does the absence of hypertension rule out ischemic renal disease? Which mechanism is most relevant?

Explanation

No. Bilateral compromised inflow can produce chronic renal ischemia and insufficiency even without hypertension.

Slide 61 · Case 3: Contrasting renal vascular lesions

Clinical vignette

A patient has unilateral renal artery narrowing, a small ischemic kidney, and pronounced arteriolosclerosis in the opposite kidney.

Interpret

Which lesion is attributed mainly to hypoperfusion, and which to systemic pressure?

Explanation

Ischemic atrophy is expected in the stenotic kidney; More marked pressure-related arteriolosclerosis may develop contralaterally.

Slide 62 · Synthesis: Three useful vascular patterns

Pattern

Primary lesion

Dominant pathology

Renal artery atheroma

Proximal large-vessel narrowing

Renin-driven hypertension or chronic ischemia

Hypertensive nephrosclerosis

Arteries and arterioles

Patchy ischemic atrophy and glomerulosclerosis

Atheroembolism

Distal arterial plaque fragments

Cholesterol-cleft emboli; Variable AKI

Slide 63 · Final clinicopathologic synthesis

Atherosclerotic renal artery narrowing often occurs near the arterial origin.

Unilateral disease may produce renin-mediated hypertension.

Bilateral disease can cause chronic renal insufficiency even without hypertension.

Chronic ischemia produces renal shrinkage, tubular atrophy and interstitial fibrosis.

Distinguish fixed stenosis from nephrosclerosis, atheroembolism and infarction.

Slide 64 · Primary source and interpretation boundaries

Robbins, Cotran & Kumar: Pathologic Basis of Disease

11th edition (2026) • Chapter 20: The Kidney

Atherosclerotic Ischemic Renal Disease — p. 855

Parent sections: Nephrosclerosis (pp. 851–852) and Renal Artery Stenosis (pp. 852–853).

Adjacent differential context: Atheroembolic Renal Disease and Renal Infarcts.

No original textbook histology images reproduced; all schematics are native editable illustrations.

Privacy preferences

Essential storage remembers your theme and privacy choice. Secure forms and teaching requests remain available whichever option you choose.

Teaching activity uses separate aggregate counters and short-lived sessions. SlideShare links open the original presentations on SlideShare. Form security checks are provided by third parties.

No message text, email addresses, visitor identifiers, or destination URLs are included in optional measurement. Read privacy details